Upstream Bio, Stock Today

UPB Stock   18.19  0.39  2.19%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 9

 
High
 
Low
Low
Upstream Bio, is trading at 18.19 as of the 25th of November 2024, a 2.19% up since the beginning of the trading day. The stock's open price was 17.8. Upstream Bio, has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Upstream Bio, are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.
IPO Date
11th of October 2024
Category
Healthcare
Upstream Bio, is entity of United States. It is traded as Stock on NASDAQ exchange. More on Upstream Bio,

Moving against Upstream Stock

  0.77VINC Vincerx PharmaPairCorr
  0.56DTIL Precision BioSciencesPairCorr
  0.56VRCA Verrica PharmaceuticalsPairCorr
  0.47DRMA Dermata TherapeuticsPairCorr
  0.42DRTS Alpha Tau MedicalPairCorr
  0.39VIRX Viracta TherapeuticsPairCorr

Upstream Stock Highlights

CEO DirectorMD MPH
Business ConcentrationPharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Upstream Bio, (UPB) is traded on NASDAQ Exchange in USA. It is located in 890 Winter Street, Waltham, MA, United States, 02451 and employs 10 people. Upstream Bio, is listed under Pharmaceutical Products category by Fama And French industry classification. The company runs under Healthcare sector within Biotechnology industry.
Check Upstream Bio, Probability Of Bankruptcy

Upstream Bio, Historical Income Statement

View More Fundamentals

Upstream Stock Against Markets

Upstream Bio, Corporate Management

Maryse MSVP OperationsProfile
Sumathi MDVP DevelopmentProfile
Parika MSHead OperationsProfile
Aaron MDChief DevelopmentProfile
Fang XieVice BiometricsProfile
Mersedeh PharmDSenior QualityProfile
Adam MBAChief OfficerProfile
When determining whether Upstream Bio, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Upstream Bio,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Upstream Bio, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Upstream Bio, Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Upstream Bio,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio,. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Upstream Bio, is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio,'s market value can be influenced by many factors that don't directly affect Upstream Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.